Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/06/2875682/0/en/EyePoint-Pharmaceuticals-Announces-Topline-Data-from-the-Phase-2-PAVIA-Trial-of-DURAVYU-in-Non-Proliferative-Diabetic-Retinopathy.html
https://www.fiercepharma.com/drug-delivery/eyepoint-reports-midstage-trial-fail-duravyu-raising-questions-about-program
https://www.defenseworld.net/2024/04/27/mirae-asset-global-investments-co-ltd-purchases-882-shares-of-eyepoint-pharmaceuticals-inc-nasdaqeypt.html#google_vignette
https://www.globenewswire.com/news-release/2024/04/16/2863443/0/en/EyePoint-Pharmaceuticals-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/04/02/2855773/0/en/EyePoint-Pharmaceuticals-Expands-Scientific-Advisory-Board-with-World-Renowned-Retina-Specialists.html
https://www.globenewswire.com/news-release/2024/03/18/2847663/0/en/EyePoint-Pharmaceuticals-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4.html
https://finance.yahoo.com/news/eyepoint-pharmaceuticals-inc-nasdaq-eypt-133226809.html
https://www.globenewswire.com//news-release/2024/03/07/2842099/0/en/EyePoint-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Highlights-Recent-Corporate-Developments.html
https://www.globenewswire.com//news-release/2024/03/04/2839395/0/en/EyePoint-Pharmaceuticals-Announces-Appointment-of-Ramiro-Ribeiro-M-D-Ph-D-as-Chief-Medical-Officer.html
https://www.globenewswire.com//news-release/2024/02/29/2837829/0/en/EyePoint-Pharmaceuticals-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results-on-March-7-2024.html